GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » 5-Year ROIIC %

Surgical Innovations Group (LSE:SUN) 5-Year ROIIC % : 27.20% (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Surgical Innovations Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 27.20%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Surgical Innovations Group's 5-Year ROIIC % or its related term are showing as below:

LSE:SUN's 5-Year ROIIC % is ranked better than
81.25% of 784 companies
in the Medical Devices & Instruments industry
Industry Median: 0.135 vs LSE:SUN: 27.20

Surgical Innovations Group 5-Year ROIIC % Historical Data

The historical data trend for Surgical Innovations Group's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group 5-Year ROIIC % Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.79 -13.17 -29.72 30.78 27.20

Surgical Innovations Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 30.78 - 27.20 -

Competitive Comparison of Surgical Innovations Group's 5-Year ROIIC %

For the Medical Devices subindustry, Surgical Innovations Group's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's 5-Year ROIIC % falls into.



Surgical Innovations Group 5-Year ROIIC % Calculation

Surgical Innovations Group's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -0.4111296 (Dec. 2023) - 0.4885066 (Dec. 2018) )/( 11.476 (Dec. 2023) - 14.783 (Dec. 2018) )
=-0.8996362/-3.307
=27.20%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Surgical Innovations Group  (LSE:SUN) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Surgical Innovations Group 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.

Surgical Innovations Group Headlines

From GuruFocus

Q4 2023 Sunoco LP Earnings Call Transcript

By GuruFocus Research 02-15-2024

Sunoco LP (SUN) Shares Up 2.85% on Sep 23

By GuruFocus Research 09-23-2024

Q1 2023 Sunoco LP Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q2 2023 Sunoco LP Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q3 2022 Sunoco LP Earnings Call Transcript

By GuruFocus Research 02-11-2024

Sunoco LP (SUN) Shares Up 3.32% on Sep 12

By GuruFocus Research 09-12-2024